• Publications
  • Influence
Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy
Purpose: The ISTANA (IRESSA as Second-line Therapy in Advanced NSCLC—KoreA) study compared gefitinib with docetaxel in patients with advanced or metastatic non–small cell lung carcinoma (NSCLC)Expand
  • 168
  • 20
  • PDF
Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.
PURPOSE To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patientsExpand
  • 282
  • 19
  • PDF
Compressive strains at physiological frequencies influence the metabolism of chondrocytes seeded in agarose
  • D. Lee, D. Bader
  • Medicine
  • Journal of orthopaedic research : official…
  • 1 March 1997
Articular cartilage is subjected to dynamic compressive loading that is known to influence chondrocyte metabolism. While the exact signalling mechanisms are unclear, it has been proposed that cellExpand
  • 388
  • 18
E‐cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer
To extend earlier observations of germline E‐cadherin mutations in kindreds with an inherited susceptibility to diffuse gastric cancer, we searched for germline E‐cadherin mutations in five furtherExpand
  • 252
  • 16
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial.
BACKGROUND Optimum management strategies for patients with advanced non-small-cell lung cancer (NSCLC) with acquired resistance to EGFR tyrosine-kinase inhibitors are undefined. We aimed to assessExpand
  • 239
  • 16
Nonmelanoma skin cancer.
  • D. Lee, S. Miller
  • Medicine
  • Facial plastic surgery clinics of North America
  • 1 August 2009
This article provides readers with a comprehensive review of the evaluation and management of nonmelanoma skin cancers. Treatment recommendations are heavily based on the most recent guidelines fromExpand
  • 243
  • 13
Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
PURPOSE To evaluate the long-term outcomes of radiofrequency ablation (RFA) as a first-line therapy for early-stage hepatocellular carcinoma (HCC) and determine the prognostic factors for survival.Expand
  • 156
  • 11
The metabolism of human mesenchymal stem cells during proliferation and differentiation
Human mesenchymal stem cells (MSCs) reside under hypoxic conditions in vivo, between 4% and 7% oxygen. Differentiation of MSCs under hypoxic conditions results in inhibited osteogenesis, whileExpand
  • 198
  • 11
Differences in the Tumor Microenvironment between African-American and European-American Breast Cancer Patients
Background African-American breast cancer patients experience higher mortality rates than European-American patients despite having a lower incidence of the disease. We tested the hypothesis thatExpand
  • 139
  • 11